Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease A Tinsley, S Navabi, ED Williams, G Liu, L Kong, MD Coates, K Clarke Inflammatory Bowel Diseases, 2018 | 148 | 2018 |
Influences and impact of anxiety and depression in the setting of inflammatory bowel disease S Navabi, VS Gorrepati, S Yadav, J Chintanaboina, S Maher, P Demuth, ... Inflammatory bowel diseases 24 (11), 2303-2308, 2018 | 132 | 2018 |
Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce … JG Stine, I Schreibman, S Navabi, M Kang, J Dahmus, C Soriano, G Rivas, ... Contemporary Clinical Trials Communications 18, 100560, 2020 | 17 | 2020 |
Predictors of 30-Day Mortality in Hospitalized Patients with Clostridium difficile Infection. J Chintanaboina, S Navabi, K Suchniak-Mussari, B Stern, S Bedi, ... Southern Medical Journal 110 (8), 546-549, 2017 | 17 | 2017 |
Sa1833 - Abdominal Pain in Inflammatory Bowel Disease Impacts Dietary Habits Independently of Inflammation EW Matthew Coates, Christopher Soriano, Seyedehsan Navabi, Venkata Subhash ... Gastroenterology 154 (6), S-413, 2018 | 4 | 2018 |
Erratum to increased risk of influenza and influenza-related complications among 140,480 patients with inflammatory bowel disease A Tinsley, S Navabi, ED Williams, G Liu, L Kong, MD Coates, K Clarke Inflammatory bowel diseases 25 (10), e135-e135, 2019 | 3 | 2019 |
P469 Effect of mirikizumab on clinical and endoscopic outcomes based on prior advanced therapy failure in patients with moderately to severely active ulcerative colitis S Navabi, G D’Haens, KH Samaan, X Li, V Arora, I Redondo, S Danese Journal of Crohn's and Colitis 17 (Supplement_1), i598-i598, 2023 | 2 | 2023 |
Liver Failure: Acute and Acute on Chronic NT Pyrsopoulos Springer International Publishing, 2020 | 2 | 2020 |
Looking Past Orthotopic Liver Transplantation: A Review of Emerging Strategies for Managing Acute and Acute-on-Chronic Liver Failure R Brumer, S Navabi, N Pyrsopoulos Liver Failure: Acute and Acute on Chronic, 355-373, 2020 | 2 | 2020 |
OP14 Effect of mirikizumab on clinical and endoscopic outcomes after 1 anti-TNF failure in patients with moderately to severely active Ulcerative Colitis A Hart, MD Martín-Arranz, D Laharie, K Matsuoka, E Dhesi, I Redondo, ... Journal of Crohn's and Colitis 18 (Supplement_1), i27-i28, 2024 | 1 | 2024 |
Improvement in bowel urgency is associated with stool frequency and rectal bleeding remission at 12 and 52 weeks in patients with moderately-to-severely active ulcerative colitis M Long, J Gisbert, K McGinnis, M Ferrante, G Rogler, C Sapin, T Hunter, ... Inflammatory Bowel Diseases 29 (Supplement_1), S10-S11, 2023 | 1 | 2023 |
S1454 Association of Body Mass Index in Patients After Bariatric Surgery With the Onset of Pancreatic Cancer: A Nationwide Inpatient Sample Database Analysis V Wong, K Amer, A Manoharan, S Daghash, S Navabi Official journal of the American College of Gastroenterology| ACG 117 (10S …, 2022 | 1 | 2022 |
Hyponatremia is protective Against the development of portal vein thrombosis in patients undergoing liver transplant D Bezinover, S Navabi, M Wang, Z Li, M William, JG Stine Transplantation proceedings 51 (6), 1880-1886, 2019 | 1 | 2019 |
P-096 The Influence of Affective Spectrum Disorders on Symptom Burden within Inflammatory Bowel Disease Populations M Coates, S Gorrepati Venkata, S Navabi, A Stuart, A Bobb, W Koltun, ... Inflammatory Bowel Diseases 23 (suppl_1), S36-S36, 2017 | 1 | 2017 |
P93 Effect of mirikizumab on clinical and endoscopic outcomes after 1 anti-TNF failure in patients with moderately-to-severely active ulcerative colitis A Hart, MD Martín-Arranz, D Laharie, K Matsuoka, E Dhesi, I Redondo, ... Gut 73 (Suppl 1), A106-A106, 2024 | | 2024 |
Su1818 EFFECT OF MIRIKIZUMAB ON CLINICAL AND ENDOSCOPIC OUTCOMES AFTER 1 ANTI-TNF FAILURE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS A Hart, MD Martín-Arranz, D Laharie, K Matsuoka, E Dhesi, I Redondo, ... Gastroenterology 166 (5), S-828, 2024 | | 2024 |
S1139 Extended Induction of Mirikizumab Sustains Efficacy and Safety Over 104 Weeks for Patients With Moderately to Severely Active Ulcerative Colitis Refractory to Initial … G D'Haens, S Navabi, F Chan-Diehl, RE Moses, J Walter, TH Gibble, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
S917 Mirikizumab Achieved Comprehensive Disease Control in Patients With Ulcerative Colitis From Phase 3 LUCENT-1 and LUCENT-2 Trials S Navabi, S Schreiber, A Keohane, S Baygani, TH Gibble, J Wu Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
Sex and Racial Disparities in Cardiovascular Disease Risk and Major Adverse Cardiac and Cerebrovascular Events in NAFLD: A National Inpatient Sample Analysis (2019) VP Shah, AM Ahmed, C Choi, SAK Hosseini, S Navabi, S Ahlawat AMERICAN JOURNAL OF GASTROENTEROLOGY 117 (10), S652-S653, 2022 | | 2022 |
S900 Risk Factors for Bowel Obstruction in Ulcerative Colitis Patients VP Shah, AM Ahmed, C Choi, SAK Hosseini, S Navabi, S Ahlawat Official journal of the American College of Gastroenterology| ACG 117 (10S …, 2022 | | 2022 |